カテゴリー： Market Monitor Global, 世界, 医療/バイオ

全身性アスペルギルス症及び全身性カンジダ症治療の世界市場見通し2023年-2029年

◆英語タイトル：Systemic Aspergillosis and Systemic Candidiasis Treatment Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23FB2226）◆商品コード：MMG23FB2226
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年2月
◆ページ数：102
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の全身性アスペルギルス症及び全身性カンジダ症治療市場規模と予測を収録しています。・世界の全身性アスペルギルス症及び全身性カンジダ症治療市場：売上、2018年-2023年、2024年-2029年
・世界の全身性アスペルギルス症及び全身性カンジダ症治療市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の全身性アスペルギルス症及び全身性カンジダ症治療市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ボリコナゾール」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

全身性アスペルギルス症及び全身性カンジダ症治療のグローバル主要企業は、Basilea Pharmaceutica、Astellas Pharma、Ferrer International、Pacgen Life Science、NovaDigm Therapeutics、Cidara Therapeutics、Amplyx Pharmaceuticals、Pfizer、Novartis、Sanofi、Merck、Bayer、GlaxoSmithKline、Abbott、Ciplaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、全身性アスペルギルス症及び全身性カンジダ症治療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の全身性アスペルギルス症及び全身性カンジダ症治療市場：タイプ別、2018年-2023年、2024年-2029年
世界の全身性アスペルギルス症及び全身性カンジダ症治療市場：タイプ別市場シェア、2022年
・ボリコナゾール、リポソームアムホテリシンB、全身経口アゾール、外用抗真菌剤、その他

世界の全身性アスペルギルス症及び全身性カンジダ症治療市場：用途別、2018年-2023年、2024年-2029年
世界の全身性アスペルギルス症及び全身性カンジダ症治療市場：用途別市場シェア、2022年
・慢性肺アスペルギルス症（CPA）、アレルギー性気管支肺アスペルギルス症（ABPA）、消化管カンジダ症、泌尿生殖器カンジダ症、その他

世界の全身性アスペルギルス症及び全身性カンジダ症治療市場：地域・国別、2018年-2023年、2024年-2029年
世界の全身性アスペルギルス症及び全身性カンジダ症治療市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における全身性アスペルギルス症及び全身性カンジダ症治療のグローバル売上、2018年-2023年
・主要企業における全身性アスペルギルス症及び全身性カンジダ症治療のグローバル売上シェア、2022年
・主要企業における全身性アスペルギルス症及び全身性カンジダ症治療のグローバル販売量、2018年-2023年
・主要企業における全身性アスペルギルス症及び全身性カンジダ症治療のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Basilea Pharmaceutica、Astellas Pharma、Ferrer International、Pacgen Life Science、NovaDigm Therapeutics、Cidara Therapeutics、Amplyx Pharmaceuticals、Pfizer、Novartis、Sanofi、Merck、Bayer、GlaxoSmithKline、Abbott、Cipla

*************************************************************

・調査・分析レポートの概要
全身性アスペルギルス症及び全身性カンジダ症治療市場の定義
市場セグメント
世界の全身性アスペルギルス症及び全身性カンジダ症治療市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の全身性アスペルギルス症及び全身性カンジダ症治療市場規模
世界の全身性アスペルギルス症及び全身性カンジダ症治療市場規模：2022年 VS 2029年
世界の全身性アスペルギルス症及び全身性カンジダ症治療市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの全身性アスペルギルス症及び全身性カンジダ症治療の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の全身性アスペルギルス症及び全身性カンジダ症治療製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ボリコナゾール、リポソームアムホテリシンB、全身経口アゾール、外用抗真菌剤、その他
全身性アスペルギルス症及び全身性カンジダ症治療のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：慢性肺アスペルギルス症（CPA）、アレルギー性気管支肺アスペルギルス症（ABPA）、消化管カンジダ症、泌尿生殖器カンジダ症、その他
全身性アスペルギルス症及び全身性カンジダ症治療の用途別グローバル売上・予測

・地域別市場分析
地域別全身性アスペルギルス症及び全身性カンジダ症治療市場規模 2022年と2029年
地域別全身性アスペルギルス症及び全身性カンジダ症治療売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Basilea Pharmaceutica、Astellas Pharma、Ferrer International、Pacgen Life Science、NovaDigm Therapeutics、Cidara Therapeutics、Amplyx Pharmaceuticals、Pfizer、Novartis、Sanofi、Merck、Bayer、GlaxoSmithKline、Abbott、Cipla
...

This report aims to provide a comprehensive presentation of the global market for Systemic Aspergillosis and Systemic Candidiasis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Systemic Aspergillosis and Systemic Candidiasis Treatment. This report contains market size and forecasts of Systemic Aspergillosis and Systemic Candidiasis Treatment in global, including the following market information:
Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Systemic Aspergillosis and Systemic Candidiasis Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Voriconazole Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Systemic Aspergillosis and Systemic Candidiasis Treatment include Basilea Pharmaceutica, Astellas Pharma, Ferrer International, Pacgen Life Science, NovaDigm Therapeutics, Cidara Therapeutics, Amplyx Pharmaceuticals, Pfizer and Novartis, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Systemic Aspergillosis and Systemic Candidiasis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
[Total Market by Segment]
Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Segment Percentages, by Type, 2022 (%)
Voriconazole
Liposomal Amphotericin B
Systemic Oral Azoles
Topical Antifungal Agents
Others
Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Segment Percentages, by Application, 2022 (%)
Chronic Pulmonary Aspergillosis (CPA)
Allergic Bronchopulmonary Aspergillosis (ABPA)
Gastrointestinal Candidiasis
Genitourinary Tract Candidiasis
Others
Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Systemic Aspergillosis and Systemic Candidiasis Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Systemic Aspergillosis and Systemic Candidiasis Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Basilea Pharmaceutica
Astellas Pharma
Ferrer International
Pacgen Life Science
NovaDigm Therapeutics
Cidara Therapeutics
Amplyx Pharmaceuticals
Pfizer
Novartis
Sanofi
Merck
Bayer
GlaxoSmithKline
Abbott
Cipla
Outline of Major Chapters:
Chapter 1: Introduces the definition of Systemic Aspergillosis and Systemic Candidiasis Treatment, market overview.
Chapter 2: Global Systemic Aspergillosis and Systemic Candidiasis Treatment market size in revenue.
Chapter 3: Detailed analysis of Systemic Aspergillosis and Systemic Candidiasis Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Systemic Aspergillosis and Systemic Candidiasis Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Systemic Aspergillosis and Systemic Candidiasis Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Overall Market Size
2.1 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size: 2022 VS 2029
2.2 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Systemic Aspergillosis and Systemic Candidiasis Treatment Players in Global Market
3.2 Top Global Systemic Aspergillosis and Systemic Candidiasis Treatment Companies Ranked by Revenue
3.3 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue by Companies
3.4 Top 3 and Top 5 Systemic Aspergillosis and Systemic Candidiasis Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Systemic Aspergillosis and Systemic Candidiasis Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Systemic Aspergillosis and Systemic Candidiasis Treatment Players in Global Market
3.6.1 List of Global Tier 1 Systemic Aspergillosis and Systemic Candidiasis Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Systemic Aspergillosis and Systemic Candidiasis Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size Markets, 2022 & 2029
4.1.2 Voriconazole
4.1.3 Liposomal Amphotericin B
4.1.4 Systemic Oral Azoles
4.1.5 Topical Antifungal Agents
4.1.6 Others
4.2 By Type – Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue & Forecasts
4.2.1 By Type – Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, 2018-2023
4.2.2 By Type – Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, 2024-2029
4.2.3 By Type – Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2022 & 2029
5.1.2 Chronic Pulmonary Aspergillosis (CPA)
5.1.3 Allergic Bronchopulmonary Aspergillosis (ABPA)
5.1.4 Gastrointestinal Candidiasis
5.1.5 Genitourinary Tract Candidiasis
5.1.6 Others
5.2 By Application – Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue & Forecasts
5.2.1 By Application – Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, 2018-2023
5.2.2 By Application – Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, 2024-2029
5.2.3 By Application – Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2022 & 2029
6.2 By Region – Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue & Forecasts
6.2.1 By Region – Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, 2018-2023
6.2.2 By Region – Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, 2024-2029
6.2.3 By Region – Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, 2018-2029
6.3.2 US Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.3.3 Canada Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.3.4 Mexico Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, 2018-2029
6.4.2 Germany Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.4.3 France Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.4.4 U.K. Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.4.5 Italy Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.4.6 Russia Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.4.7 Nordic Countries Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.4.8 Benelux Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, 2018-2029
6.5.2 China Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.5.3 Japan Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.5.4 South Korea Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.5.5 Southeast Asia Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.5.6 India Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, 2018-2029
6.6.2 Brazil Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.6.3 Argentina Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, 2018-2029
6.7.2 Turkey Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.7.3 Israel Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.7.4 Saudi Arabia Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
6.7.5 UAE Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size, 2018-2029
7 Systemic Aspergillosis and Systemic Candidiasis Treatment Companies Profiles
7.1 Basilea Pharmaceutica
7.1.1 Basilea Pharmaceutica Company Summary
7.1.2 Basilea Pharmaceutica Business Overview
7.1.3 Basilea Pharmaceutica Systemic Aspergillosis and Systemic Candidiasis Treatment Major Product Offerings
7.1.4 Basilea Pharmaceutica Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue in Global Market (2018-2023)
7.1.5 Basilea Pharmaceutica Key News & Latest Developments
7.2 Astellas Pharma
7.2.1 Astellas Pharma Company Summary
7.2.2 Astellas Pharma Business Overview
7.2.3 Astellas Pharma Systemic Aspergillosis and Systemic Candidiasis Treatment Major Product Offerings
7.2.4 Astellas Pharma Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue in Global Market (2018-2023)
7.2.5 Astellas Pharma Key News & Latest Developments
7.3 Ferrer International
7.3.1 Ferrer International Company Summary
7.3.2 Ferrer International Business Overview
7.3.3 Ferrer International Systemic Aspergillosis and Systemic Candidiasis Treatment Major Product Offerings
7.3.4 Ferrer International Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue in Global Market (2018-2023)
7.3.5 Ferrer International Key News & Latest Developments
7.4 Pacgen Life Science
7.4.1 Pacgen Life Science Company Summary
7.4.2 Pacgen Life Science Business Overview
7.4.3 Pacgen Life Science Systemic Aspergillosis and Systemic Candidiasis Treatment Major Product Offerings
7.4.4 Pacgen Life Science Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue in Global Market (2018-2023)
7.4.5 Pacgen Life Science Key News & Latest Developments
7.5 NovaDigm Therapeutics
7.5.1 NovaDigm Therapeutics Company Summary
7.5.2 NovaDigm Therapeutics Business Overview
7.5.3 NovaDigm Therapeutics Systemic Aspergillosis and Systemic Candidiasis Treatment Major Product Offerings
7.5.4 NovaDigm Therapeutics Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue in Global Market (2018-2023)
7.5.5 NovaDigm Therapeutics Key News & Latest Developments
7.6 Cidara Therapeutics
7.6.1 Cidara Therapeutics Company Summary
7.6.2 Cidara Therapeutics Business Overview
7.6.3 Cidara Therapeutics Systemic Aspergillosis and Systemic Candidiasis Treatment Major Product Offerings
7.6.4 Cidara Therapeutics Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue in Global Market (2018-2023)
7.6.5 Cidara Therapeutics Key News & Latest Developments
7.7 Amplyx Pharmaceuticals
7.7.1 Amplyx Pharmaceuticals Company Summary
7.7.2 Amplyx Pharmaceuticals Business Overview
7.7.3 Amplyx Pharmaceuticals Systemic Aspergillosis and Systemic Candidiasis Treatment Major Product Offerings
7.7.4 Amplyx Pharmaceuticals Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue in Global Market (2018-2023)
7.7.5 Amplyx Pharmaceuticals Key News & Latest Developments
7.8 Pfizer
7.8.1 Pfizer Company Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Systemic Aspergillosis and Systemic Candidiasis Treatment Major Product Offerings
7.8.4 Pfizer Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue in Global Market (2018-2023)
7.8.5 Pfizer Key News & Latest Developments
7.9 Novartis
7.9.1 Novartis Company Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Systemic Aspergillosis and Systemic Candidiasis Treatment Major Product Offerings
7.9.4 Novartis Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue in Global Market (2018-2023)
7.9.5 Novartis Key News & Latest Developments
7.10 Sanofi
7.10.1 Sanofi Company Summary
7.10.2 Sanofi Business Overview
7.10.3 Sanofi Systemic Aspergillosis and Systemic Candidiasis Treatment Major Product Offerings
7.10.4 Sanofi Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue in Global Market (2018-2023)
7.10.5 Sanofi Key News & Latest Developments
7.11 Merck
7.11.1 Merck Company Summary
7.11.2 Merck Business Overview
7.11.3 Merck Systemic Aspergillosis and Systemic Candidiasis Treatment Major Product Offerings
7.11.4 Merck Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue in Global Market (2018-2023)
7.11.5 Merck Key News & Latest Developments
7.12 Bayer
7.12.1 Bayer Company Summary
7.12.2 Bayer Business Overview
7.12.3 Bayer Systemic Aspergillosis and Systemic Candidiasis Treatment Major Product Offerings
7.12.4 Bayer Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue in Global Market (2018-2023)
7.12.5 Bayer Key News & Latest Developments
7.13 GlaxoSmithKline
7.13.1 GlaxoSmithKline Company Summary
7.13.2 GlaxoSmithKline Business Overview
7.13.3 GlaxoSmithKline Systemic Aspergillosis and Systemic Candidiasis Treatment Major Product Offerings
7.13.4 GlaxoSmithKline Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue in Global Market (2018-2023)
7.13.5 GlaxoSmithKline Key News & Latest Developments
7.14 Abbott
7.14.1 Abbott Company Summary
7.14.2 Abbott Business Overview
7.14.3 Abbott Systemic Aspergillosis and Systemic Candidiasis Treatment Major Product Offerings
7.14.4 Abbott Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue in Global Market (2018-2023)
7.14.5 Abbott Key News & Latest Developments
7.15 Cipla
7.15.1 Cipla Company Summary
7.15.2 Cipla Business Overview
7.15.3 Cipla Systemic Aspergillosis and Systemic Candidiasis Treatment Major Product Offerings
7.15.4 Cipla Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue in Global Market (2018-2023)
7.15.5 Cipla Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 全身性アスペルギルス症及び全身性カンジダ症治療の世界市場見通し2023年-2029年(Systemic Aspergillosis and Systemic Candidiasis Treatment Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 6次元治療ベッドのグローバル市場展望 2023年-2029年：ヘッドトリートメント、全身療法、その他
  • 四肢麻痺治療の世界市場見通し2023年-2029年
  • 慢性閉塞性肺疾患治療薬の世界市場見通し2023年-2029年
  • 非結核性抗酸菌治療の世界市場見通し2023年-2029年
  • 血液腫瘍治療の世界市場見通し2023年-2029年